Abstract topics

Please choose one topic out of the categories that best describes the content of your abstract.

1.1 Venous thrombosis
1.2 Pulmonary embolism and pulmonary hypertension
1.3 Arterial thrombosis
1.4 Antiphospholipid syndrome
1.5 Thromboembolism and cancer
1.6 Others

2.1 Coagulation and fibrinolytic factors – physiology
2.2 Haemophilia
2.3 von Willebrand disease
2.4 Acquired coagulation disorders/inhibitors
2.5 General management of bleeding
2.6 Rare bleeding disorders
2.7 Others

3.1 Physiology
3.2 Acquired thrombocytopenias
3.3 Inherited thrombocytopenias
3.4 Platelet dysfunction
3.5 Other related topics

4.1 Endothelial cells
4.2 Angiogenesis and tissue repair
4.3 Biorheology
4.4 Adhesion molecules, including von Willebrand factor
4.5 Extracellular microvesicles
4.6 Other related topics
4.7 Others

5.1 Oral anticoagulants – non vitamin K dependent
5.2 Oral anticoagulants – vitamin K dependent
5.3 Parenteral anticoagulants
5.4 Antidots and anticoagulants
5.5 Anti-platelet drugs
5.6 Thromboytic agents
5.7 Coagulation factors and inhibitors
5.8 Others

6.1 Biomarkers
6.2 Endogenous thrombin potential
6.3 Control of non-vitamin K dependent oral anticoagulants
6.4 Quality management and laboratory organisation
6.5 Point-of-care haemostasis testing
5.6 Issues related to new factor concentrates
6.7 Others

9.1 Cancer and haemostasis
9.2 Tissue repair and angiogenesis
9.3 Fibrinolysis and proteolysis – protein structure
9.4 Inflammatory disorders
9.5 Others

10.1 TTP; HUS
10.2 Septicaemia, disseminated intravascular coagulation (DIC)
10.3 Trauma induced coagulopathy (TIC)
10.4 Haemostasis and intensive care medicine
10.5 Organ induced coagulopathy
10.6 Perioperative bleeding disorders
10.7 Perioperative thrombosis
10.8 Others

Abstract Guidelines

  • Abstract text is limited to 3,000 characters
  • Abstracts must be submitted in English
  • Please structure your abstract as follows:
    • Scientific research question
    • Methodology
    • Findings
    • Conclusion
  • One table and one graphic can be used, literature references should not be included
  • All abstracts must contain original work
  • Please indicate your preferred type of presentation (oral or poster) and choose a topic from the drop-down list
  • Please check spelling and grammar carefully. All abstracts will be published as submitted
  • Use generic names. Commercial drug names may not be used